Basics |
Bionano Genomics, Inc.
|
IPO Date: |
September 21, 2018 |
Sector: |
Healthcare |
Industry: |
Diagnostics and Research |
Market Cap: |
$18.68M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.12 | 4.53%
|
Avg Daily Range (30 D): |
$0.13 | 3.76%
|
Avg Daily Range (90 D): |
$0.10 | 2.76%
|
Institutional Daily Volume |
Avg Daily Volume: |
8.27M |
Avg Daily Volume (30 D): |
.12M |
Avg Daily Volume (90 D): |
.1M |
Trade Size |
Avg Trade Size (Sh.): |
365 |
Avg Trade Size (Sh.) (30 D): |
148 |
Avg Trade Size (Sh.) (90 D): |
136 |
Institutional Trades |
Total Inst.Trades: |
870 |
Avg Inst. Trade: |
$1.76M |
Avg Inst. Trade (30 D): |
$.7M |
Avg Inst. Trade (90 D): |
$.7M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$2.59M |
Avg Closing Trade (30 D): |
$.7M |
Avg Closing Trade (90 D): |
$.7M |
Avg Closing Volume: |
.98K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-43.77
|
$-1.99
|
$-1.15
|
Diluted EPS
|
$-43.77
|
$-1.99
|
$-1.15
|
Revenue
|
$ 27.43M
|
$ 6.73M
|
$ 6.46M
|
Gross Profit
|
$ 1.39M
|
$ 3.48M
|
$ 2.94M
|
Net Income / Loss
|
$ -74.33M
|
$ -6.86M
|
$ -3.1M
|
Operating Income / Loss
|
$ -72.11M
|
$ -7.8M
|
$ -8.47M
|
Cost of Revenue
|
$ 26.04M
|
$ 3.26M
|
$ 3.52M
|
Net Cash Flow
|
$ -18.27M
|
$ -.06M
|
$ -5.95M
|
PE Ratio
|
|
|
|
Splits |
Jan 27, 2025:
1:60
|
Aug 07, 2023:
1:10
|
|
|
|